Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Clinical Chemistry

Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Stool testing performs well for colorectal cancer triage, but age-specific thresholds may improve referrals. More...
19 Nov 2026
DB function failed with error number 0

Experimental Blood Test Detects Markers of Three Cancers and Alzheimer’s Disease

More...
18 Nov 2026
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

New data show clozapine neutropenia risk peaks early and falls, supporting reduced blood monitoring after two years. More...
18 Nov 2026
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

C2N Diagnostics has launched C2N-Aβ-MAA (6x), a plasma multi-analyte assay for amyloid beta (Aβ) proteins. More...
17 Nov 2026
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

A new p-tau217 blood test model with age and genetics estimates 5- and 10-year risk of cognitive impairment. More...
16 Nov 2026
Image: The cobas Mass Spec solution combines the high specificity, sensitivity, and accuracy of mass spectrometry with an automated, standardized workflow. (Photo courtesy of Roche)

FDA Authorization Adds Gabapentin Testing to Roche Mass Spectrometry Solution

Roche received FDA De Novo authorization for the cobas pro i 601 platform with the Ionify Gabapentin assay, components of its cobas Mass Spec solution. More...
16 Nov 2026
Image: Joy Milne, whose heightened sense of smell helped inspire research into the molecular signature of Parkinson’s, takes part in research investigating the sense of smell. (Image Credit: University of Manchester)

Skin Swab Research Identifies Metabolic Changes Linked to Parkinson’s Disease

A new skin swab mass spectrometry test detects a sebum-based chemical signature of Parkinson’s. More...
16 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240


The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.